Bent Jakobsen, PhD, FMedSci
Dr Bent Jakobsen is the scientific co-founder of Adaptimmune Ltd, where he provides strategic and advisory input as well as oversight of research programmes. He was previously Chief Scientific Officer of Avidex, a company he founded in 1999 as a spin-out from the University of Oxford to develop novel T cell receptor-based drugs. Dr Jakobsen, a fellow of the Acadamy of Medical Sciences, was head of the Immune Receptor Group at the Institute of Molecular Medicine (IMM) in Oxford from 1993 to July 2000. Prior to this, he was a Senior Research Fellow of the Danish Natural Research Council, Aarhus, Denmark, and undertook post-doctoral research at the Laboratory of Molecular Biology of the Medical Research Council in Cambridge. Dr Jakobsen has authored numerous scientific papers and is considered a world expert in the field of T cell receptor immunology.